$AGIO AGIOS PHARMACEUTICALS, INC. Insider Trading Week 35/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. in week 35/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 4,500 | 2,104 | 303,813 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 5,000 | 2,338 | 308,313 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 46.30 | 4,500 | 208,350 | 35,000 | 39.5 K to 35 K (-11.39 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 4,500 | 2,104 | 39,500 | 35 K to 39.5 K (+12.86 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 5,000 | 2,338 | 35,000 | 30 K to 35 K (+16.67 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,500 | 1,966 | 810,820 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 46.30 | 6,500 | 300,950 | 167,772 | 174.3 K to 167.8 K (-3.73 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 46.30 | 6,500 | 300,950 | 253,272 | 259.8 K to 253.3 K (-2.50 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,500 | 1,966 | 259,772 | 253.3 K to 259.8 K (+2.57 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 2.34 | 9,545 | 22,335 | 129,498 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Option Exercise | M | 0.69 | 455 | 313 | 139,043 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Sell | S | 46.30 | 10,000 | 463,000 | 0 | 10 K to 0 (-100.00 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 2.34 | 9,545 | 22,335 | 10,000 | 455 to 10 K (+2,097.80 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Goddard Glenn | Senior Vice Preside ... | Buy | M | 0.69 | 455 | 313 | 455 | 0 to 455 |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Option Exercise | M | 0.30 | 6,745 | 2,040 | 297,022 | |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Sell | S | 46.30 | 13,000 | 601,900 | 169,835 | 182.8 K to 169.8 K (-7.11 %) |
| Sep 03 2014 | AGIO | AGIOS PHARMACEUTIC ... | Higgons John Duncan | Chief Operating Off ... | Buy | M | 0.30 | 6,745 | 2,040 | 182,835 | 176.1 K to 182.8 K (+3.83 %) |